Measurement of cell metabolism in moderate-throughput to high-throughput organ-on-chip (OOC) systems would expand the range of data collected for studying drug effects or disease in physiologically relevant tissue models. However, current measurement approaches rely on fluorescent imaging or colorimetric assays that are focused on endpoints, require labels or added substrates, and lack real-time data. Here, we integrated optical-based oxygen sensors in a high-throughput OOC platform and developed an approach for monitoring cell metabolic activity in an array of membrane bilayer devices. Each membrane bilayer device supported a culture of human renal proximal tubule epithelial cells on a porous membrane suspended between two microchannels and exposed to controlled, unidirectional perfusion and physiologically relevant shear stress for several days. For the first time, we measured changes in oxygen in a membrane bilayer format and used a finite element analysis model to estimate cell oxygen consumption rates (OCRs), allowing comparison with OCRs from other cell culture systems. Finally, we demonstrated label-free detection of metabolic shifts in human renal proximal tubule cells following exposure to FCCP, a drug known for increasing cell oxygen consumption, as well as oligomycin and antimycin A, drugs known for decreasing cell oxygen consumption. The capability to measure cell OCRs and detect metabolic shifts in an array of membrane bilayer devices contained within an industry standard microtiter plate format will be valuable for analyzing flow-responsive and physiologically complex tissues during drug development and disease research.
Drug development remains expensive and inefficient largely due to a lack of in vitro cell culture models and animal models that can accurately predict a drug’s effect in humans during clinical trials1. Microfluidic organ-on-chip (OOC) technology, a promising alternative to traditional in vitro models, allows for culturing of human tissue with precise, continuous, and long-term control of physical and chemical cues relevant to the organ under investigation2. Different OOC systems, including kidney-on-chip3, lung-on-chip4,5, and heart-on-chip6,7, have shown that the inclusion of relevant physiological cues, such as fluid flow and mechanical stress, can alter tissue morphology8, function9, and response to drug exposures10, resulting in in vitro tissue with improved human relevance compared to cells cultured in traditional systems, such as static 2D well plates.
Unfortunately, data collection from OOC systems still relies heavily on fluorescent imaging or colorimetric assays that are often focused on end points, require labels or added substrates, and generally lack kinetic data regarding cell culture conditions or cellular activity11. Integration of sensors within OOC systems has enabled label-free and real-time collection of key cell culture readouts, including oxygen levels, pH, and transepithelial/endothelial electrical resistance12. The measurement of oxygen is particularly critical in OOC systems because oxygen availability heavily influences cell function13, and the cell oxygen consumption rate (OCR) serves as a dynamic indicator of metabolic activity and mitochondrial function14. For the kidney, renal proximal tubule epithelial cells rely primarily on oxygen consumption via the mitochondria to generate sufficient energy to maintain physiological functions, including fluid/electrolyte balance and drug clearance15. Furthermore, studies have linked drug-induced nephrotoxicity and common renal diseases, including acute kidney injury and diabetic nephropathy, to mitochondrial dysfunction occurring within renal proximal tubule epithelial cells16,17. Because mitochondria are a key target in drug development, there is a need for oxygen sensor-integrated OOC systems that allow online and label-free measurement of the cell OCR to detect shifts in mitochondrial function resulting from drug treatments.
Electrochemical and optical-based sensing are two main approaches for label-free measurement of cell oxygen consumption in cell culture systems. While electrochemical-based sensing has been implemented in several static and microfluidic cell culture systems for oxygen consumption measurements, such systems are low throughput18,19,20. The limited scalability of electrochemical-based OOC systems is often attributed to the large footprint of the electrical hardware, complex fabrication processes, and the need for a reference electrode21. Optical-based sensors generally provide a low footprint, fast sensor response times, and straightforward integration with both static well plates and microfluidic devices22,23. Several optical-based systems, such as the commercial Agilent Seahorse XFeAnalyzer, offer high-throughput cell oxygen consumption measurements in traditional well plates24,25. However, they are not compatible with OOC systems and do not support perfusion during measurements. For these reasons, several groups have incorporated optical-based sensors in OOC systems to measure oxygen and cell oxygen consumption26,27,28. Unfortunately, existing systems contain only one or a few cell culture chambers situated in parallel, lack a microtiter plate format well suited for typical biological workflows, and have large footprints. Due to the above issues, the broad adoption of OOC systems in life science research and drug development has been limited. In recent years, several groups have arrayed up to 96 OOC devices in microtiter plate formats29,30; however, such systems have not yet demonstrated label-free measurement of the cell OCR. Recently, our group integrated optical-based oxygen sensor units within a high-throughput OOC platform, in which we measured oxygen consumption on the timescale of hours with low temporal resolution. The low temporal resolution of these measurements did not allow the quantification of cell OCRs or metabolic shifts29. Despite recent progress in the integration of oxygen sensors in scalable OOC systems, approaches for the measurement of cell OCRs and drug-induced metabolic shifts in such systems have yet to be reported. Additionally, cell OCR has yet to be measured in OOC systems that utilize a membrane bilayer format, in which cells are cultured on a porous membrane suspended between two microchannels, a common OOC architecture used to study human tissue barriers8,31. More specifically, localization of cells between two microchannels offers unique advantages for drug studies, including independent fluidic access to both the apical and basolateral surfaces of the tissue layer32, independent control of flow rates29, and compatibility with barrier-specific functional assays33,34.
Here, we report an approach to measure cell OCRs and drug-induced metabolic shifts in an array of membrane bilayer devices contained within an oxygen sensor-integrated microfluidic culture plate (O-MCP) in a microtiter plate format and industry-standard footprint. Each O-MCP device contained human renal proximal tubule epithelial cells (hRPTECs) cultured on a porous membrane between two microchannels with an optical-based sensor unit located in the bottom microchannel. The cells were exposed to continuous unidirectional perfusion and shear stress of 0.07 Pa, mimicking the flow conditions of the kidney’s proximal tubule segment35. We established a technique to measure oxygen depletion, changes in oxygen at the sensor in the bottom microchannel, across multiple devices by repeatedly turning flow on and off and using a programmable stage to align an optical fiber beneath each device’s sensor unit. A finite element analysis-based model of oxygen transfer was established to estimate cell OCRs from the measured oxygen depletion curves, which allowed comparison with OCRs measured in other cell culture systems. Finally, OCR data collected from the O-MCP enabled label-free detection of drug-induced metabolic shifts following exposure of hRPTECs to three mitochondrial toxicants tested in parallel on the same microtiter plate. Our system for label-free monitoring of OCR and metabolic shifts in an array of membrane bilayer devices contained within a microtiter plate format will serve as a valuable tool for data collection during pharmacological studies and disease research.
O-MCP design and oxygen measurement setup
The O-MCP was designed as a 96-device array configured to collect oxygen measurements during controlled fluid flow. Each O-MCP device was a membrane bilayer device consisting of two microchannels separated by a porous membrane. Fluid flow was controlled in each microchannel via the micropump array housed in the O-MCP lid. The oxygen sensor units, 0.75 mm in diameter and 50 μm-thick, were bonded to the center of each of the 96 bottom microchannels, as shown in Fig. 1a, resulting in a sensor unit for each device, as shown in Fig. 1b, within the O-MCP microfluidic layer. The microfluidic layer was attached to a custom bottomless 384-well plate to create the full O-MCP, as viewed from the bottom in Fig. 1c. The inset of Fig. 1c. shows a bottom view of a single O-MCP device containing four inlet and outlet wells connected to the top and bottom microchannels and a sensor unit in the bottom microchannel. A single device of the O-MCP, shown schematically in Fig. 1d, allowed flow, controlled by the micropump array, to be administered to both microchannels with independent fluid streams. Oxygen consumption from hRPTECs cultured on the membrane in the top microchannel led to changes in oxygen concentration, which were measured via the oxygen sensor unit, illustrated in Fig. 1e. An oxygen meter and optical fiber positioned below each sensor unit delivered excitation at 610–630 nm to the sensor unit and collected emission at 760–790 nm with an oxygen-dependent phase shift.
Sequential measurement of oxygen depletion across an array of membrane bilayer devices
We developed a method to measure oxygen depletion in the O-MCP array that contained hRPTECs adhered to the porous membrane. We produced temporary flow-on and flow-off conditions in each of the 96 O-MCP devices simultaneously by programming the micropump array to turn on pumping at 70 μL/min or stop pumping. Turning flow off in each microchannel resulted in a decrease in oxygen near the sensor due to cell oxygen consumption, the low oxygen permeability of the COP microchannels, and the high oxygen permeability of the porous membrane, as shown schematically in Fig. 2a. Sequential alignment of an optical fiber beneath each device and repeatedly turning flow on and off enabled measurement of oxygen depletion for multiple O-MCP devices, shown schematically in Fig. 2b. Real-time oxygen measurements were taken in a single device while the micropump array was turned on and off three consecutive times; we observed a decrease in oxygen while flow was off and a return to the baseline oxygen level when flow was turned back on. A representative plot of the changes in oxygen for one of the devices is shown in Fig. 2c. The oxygen concentration remained steady at 174 hPa, while pumps maintained 70 μL/min of media flow but decreased to 153 hPa within 3 minutes once the flow was turned off. The oxygen concentration returned to 174 hPa within 1 minute of the micropump array being turned back on. Repeated modulation of flow on for 1 minute and flow off for 1 minute coupled with indexing the optical fiber to different sensor units enabled measurement of oxygen depletion across 15 devices containing hRPTEC and hRPTEC culture medium (R-medium). Figure 2d. shows oxygen depletion for three representative devices measured consecutively during sequential measurements of 15 devices containing hRPTEC and R-medium. Initial oxygen levels prior to turning flow off were below the saturation level of 200 hPa, which was expected due to oxygen consumption from cells in the top microchannel outcompeting the oxygen supply via the pumps. Initial oxygen levels also varied slightly within the range of 165–200 hPa, which was attributed to variability in the biology within each device, such as the number of cells, location of cells within each device, and cell metabolic activity. A comparison between oxygen depletion in devices containing hRPTECs and R-medium and control devices containing R-medium without cells is shown in Fig. 2e. Oxygen remained steady at initial levels within the control devices following turning off the micropump array. In devices containing hRPTECs and R-medium, oxygen remained steady at the initial levels for 4 s after turning off the micropump array, which was attributed to residual flow in each microchannel and a diffusion distance between the cell layer and sensor.
Estimation of cell OCRs in the O-MCP
A mass transfer model describing oxygen depletion in each O-MCP device allowed estimation of OCRs for cells cultured on the membrane. In each O-MCP device, hRPTECs formed a uniform layer on the central porous membrane in the top microchannel with high viability (Fig. S1). Figure 3a. shows hRPTECs stained for DNA and actin located on the top side of the membrane in the microchannel overlap region containing the centrally located light-absorbing sensor unit, shown as a dark spot. A cross-sectional view of the microchannel overlap region in Fig. 3b. shows hRPTECs stained for DNA along the membrane and auto fluorescence from the sensor unit located on the floor of the bottom microchannel. A 2D mass transfer model following Fick’s law was proposed to simulate oxygen changes occurring in the microchannel overlap region as a result of cell oxygen consumption on the top surface of the membrane. The microchannel overlap region was discretized into two components: a top microchannel containing cells at the bottom surface and a bottom microchannel with no cells, as shown in Fig. 3c. Oxygen transfer between the COP microchannel walls and media was neglected due to the low oxygen diffusivity in COP36. Because the experimental curves were nonlinear (Fig. 2c), we proposed a model that allowed for an initial oxygen gradient between the top and bottom microchannels. Due to localization of cells to the top microchannel (including inlets and wells), oxygen concentrations were expected to be lower in the top microchannel than in the bottom microchannel prior to turning flow off. By assuming symmetry along the microchannel length, all governing and boundary equations could be simplified to 1D differential equations. The governing equations following Fick’s law in the top and bottom microchannels are given by
where the oxygen concentrations in the top and bottom microchannels are CT and CB, respectively, D is the oxygen diffusion coefficient in the cell culture medium, y is the position along the height of each microchannel, and t is time. In the top microchannel, oxygen is consumed by cells and transferred between the top and bottom microchannels across a membrane. Therefore, the boundary conditions for the top microchannel are summarized by
where hT and hB are the top and bottom microchannel heights, respectively. The membrane was modeled as a thin diffusion barrier37, where DM is an effective membrane diffusion coefficient and hM is the membrane thickness. Renal cell oxygen consumption was modeled based on Michaelis‒Menten kinetics38, where Vm is the maximum cell OCR, φ is the cell surface density on the membrane, and Km is the Michaelis constant.
In the bottom microchannel, there exists a flux at the top surface due to oxygen transfer between the top and bottom microchannels across a membrane. Therefore, the boundary conditions for the bottom microchannel are summarized in the following equations:
The above time-dependent equations were solved numerically using the forward Euler method39 in a homemade MATLAB modeling environment with the input parameters provided in Table S1. The maximum cell OCR (Vm) and initial oxygen concentrations, CT (y,0) and CT (y,0), were extracted by numerically fitting the mass transfer model to the experimental oxygen depletion curves. The curve fitting procedure was carried out via minimization of the residual sum of squares between the predicted and experimental curves using the objective function given by
where N is the number of time points, Cexp,i represents the experimental concentration at the ith time point, and Cpred,i is the predicted concentration at the floor of the bottom microchannel at the ith time point. Experimental oxygen measurements, in units of partial pressure, were converted to concentration with Henry’s law and assuming an oxygen solubility in cell culture medium of 215 μM37,40 to enable comparison with predicted curves. The curve fitting procedure resulted in simulated oxygen depletion curves that fit the experimental curves closely, as shown in data from three representative devices in Fig. 3d. and data averaged over 15 devices in Fig. 3e. The curve fitting procedure resulted in an estimated OCR for hRPTECs of 0.29 ± 0.07 pmol/h/cell, as shown in Fig. 3f, for quantification of cell metabolic activity and comparison with OCRs from other systems.
Because flow was repeatedly turned on and off during sequential device measurements, we evaluated the consistency of single device OCR readouts during repeated modulation of flow on and off. We monitored the OCR for three devices containing hRPTEC and R-medium during 31 repetitions of turning flow on at 70 μl/min for 1 minute and off for 1 minute. The OCR remained consistent across the 31 flow-off occurrences, as shown in Fig. 4a, which indicated that turning the flow on (at 70 μl/min) and off had a negligible effect on a single device’s OCR readouts. Additionally, oxygen readings measured during flow-on conditions, shown in Fig. 4b, remained consistent over the course of 31 flow-off occurrences. Therefore, repeated modulation between flow-on and flow-off conditions, necessary to acquire readings across an array of O-MCP devices using a single optical fiber, had a negligible effect on individual device OCR readouts, ensuring negligible error due to the technique.
Detection of drug-induced shifts in mitochondrial function
hRPTECs cultured under flow at 70 μl/min for 6 days responded to 1.5 μM antimycin A (Anti), 1.5 μM oligomycin (Oligo) and 2 μM trifluoromethoxy carbonyl cyanide phenylhydraxone (FCCP), which are drugs that directly interfere with mitochondrial function. Anti and Oligo, which are mitochondrial oxidative phosphorylation inhibitors, reduce cell oxygen consumption, and FCCP, a mitochondrial oxidative phosphorylation uncoupler, increases oxygen consumption41. Representative images of hRPTECs stained for nuclei and actin following a 1.5-hour exposure to Anti, Oligo, and FCCP (Fig. 5a) showed no significant differences in cell density following drug exposure (see Fig. S2). Oxygen depletion curves were acquired in devices pre- and postdrug treatment for estimation of the cell OCR via curve fitting. We found that all oxygen depletion curves and corresponding curve fits used to estimate cell OCR were in close agreement (Fig. S3). Representative oxygen depletion curves measured in devices treated with Anti, Oligo, FCCP, and no drug (control) are shown in Fig. 5b. and displayed differences in oxygen consumption as a result of drug activity. Figure 5c. shows the OCR measurements of individual devices before and after drugs were administered at t = 61.4 minutes, indicated by the dashed line in the plots, for each condition. Control devices with no drugs administered, shown in the top left graph of Fig. 5c, were measured at three time points to measure any potential changes in the OCR due to nondrug-related changes in biological activity or due to experimental handling of the system. Control readings acquired before, during, and after measurements of devices containing drugs indicated a slight decrease in the OCR. The postdrug OCR relative to the predrug OCR was computed for each device (using the first and second time points for control measurements), as shown in Fig. 5c. The postdrug OCR relative to the predrug OCR was 80% for the control, 40% for Anti, 56% for Oligo, and 176% for FCCP conditions, as reported in Table 1. Postdrug OCRs, shown in Table 1 and Fig. 5d, indicated a significant reduction in oxygen consumption due to both inhibitors (p < 0.01) and a significant increase in oxygen consumption due to FCCP, the uncoupler agent (p < 0.05).
The O-MCP had integrated sensor units in each of the 96 OOC devices, which enabled the collection of oxygen concentration data in each device one at a time via the sequential positioning of a single optical fiber below each sensor prior to measurements. The state of the art commercial Agilent Seahorse XFeAnalyzer uses 96 probes inserted into all wells of a standard 96-well plate for measurement of oxygen consumption42 but does not support perfusion and is not compatible with OOC architectures. In contrast, the O-MCP is a sensor-integrated OOC system that allows oxygen measurements during controlled perfusion in membrane bilayer devices used to study complex tissue models3,43,44. In addition to oxygen sensing, the design and fabrication of the O-MCP is easily adaptable for other sensing applications. Optical access to the bottom microchannel and a simple sensor bonding process allow for other optically based sensor units to be integrated that measure other critical cell culture parameters, including pH45 and glucose46. Additionally, for the measurement of cell culture parameters across the entire channel length while maintaining optical access for microscopic imaging, transparent liquid sensors could be deposited along the entire bottom microchannel via spray coating, similar to the procedure reported in Ehgarter et al.23. Finally, the O-MCP sensor integration has minimal hardware requirements because it easily integrates with a standard microscope, utilizing the objective turret and programmable stage for alignment of a single optical fiber beneath each sensor prior to measurements in each device. Additionally, the oxygen sensors integrate well with impedance-based sensors for the measurement of transepithelial-endothelial electrical resistance, as shown in previous work29, because there is no interference between the optical and electrical signals. For integration of multiple optical-based sensors that measure different biological parameters, such as pH or glucose, the issue of signal specificity should be further explored due to the coexistence of multiple optical signals in the same environment.
Previous groups have integrated optical-based oxygen sensors into single OOC devices and measured transient oxygen depletion by modulating the flow on and off45 and during steady-state flow-on conditions20; however, data were limited to only one or a few individual devices in parallel. The O-MCP demonstrated the capability to collect OCR data from an array of OOC devices contained in an industry-standard microtiter plate format via sequential positioning of a single optical fiber beneath each device, repeated modulation of flow on and off, and acquisition of transient oxygen depletion measurements. Additionally, in contrast to previous works, the O-MCP enabled oxygen measurements for cells cultured on a membrane between two microchannels, which is a setup well suited for studying tissue barriers and provides a mechanism to separate cells from the sensor unit. Separation of cells from the sensor unit was critical to ensure that cells formed a confluent tissue layer without obstruction from the sensor. To our knowledge, existing OCR measurement systems24,27,28 have not utilized a porous membrane to separate cells from the sensor. We also found that turning flow off for a short duration of 1 minute was sufficient to detect oxygen depletion at the sensor location due to cell oxygen consumption along the membrane. The capability to detect significant depletion in oxygen within a short measurement period was particularly useful, as it enabled sequential measurements across multiple devices situated in parallel with moderate speed (15 devices/30 minutes) using only a single optical fiber and a programmable microscope stage. Integration of an array of optical fibers with the high-throughput OOC platform would increase the data collection speed and be compatible with the current procedure.
Measurement of the cell OCR in OOC systems enables comparison with metabolic rates from different cell culture systems, improved sensitivity to biological changes and correction for nonbiological contributions to the measurements. While several studies have measured the cell OCR in single microchannels27,28,45, it remains a challenge to do so in multilayer devices and 3D cultures because the cells and integrated sensors are generally not confined to a single fluidic chamber with well-defined geometry and diffusion characteristics. Therefore, finite element analysis-based modeling has proven useful for the simulation of oxygen distributions37 and estimation of the cell OCR20 in OOC systems. Bilayer membrane devices in particular have emerged as a useful cell culture format8,31, yet current systems have not demonstrated OCR measurements. For the first time, to our knowledge, we employed a finite element analysis-based model and curve fitting approach to estimate OCR for cells localized to a porous membrane suspended between two microchannels. As a proof of concept, the OCR was measured for only one cell type cultured on the central membrane. Future work should investigate the measurement of OCR for tissue models in which two or more cell types are cultured on the membrane.
The measured OCR of 0.29 pmol/h/cell for hRPTECs in the O-MCP was in the range of human cell OCR values reported in other in vitro studies20,47 and ~six times lower than a previously reported measurement of hRPTEC OCR38. The difference between our measured OCR for hRPTECs and the previously reported value is likely due to differences in culture conditions, particularly glucose concentrations, between the two culture systems. In support of this claim, Beeson et al.48 previously demonstrated that medium conditions, particularly glucose concentrations, can heavily influence primary renal epithelial cell OCR. The 176% FCCP-induced increase in the hRPTEC OCR was similar to a previously reported 189% increase in hRPTEC OCR following treatment with CCCP, a mitochondrial uncoupler compound similar to FCCP38. Similar to previous in vitro studies48,49, Anti and Oligo decreased cell OCR; however, the magnitudes of the shifts differed relative to the literature values, which we attributed to differences in biological conditions, including cell types and culture mediums.
For the first time, to our knowledge, we measured drug-induced shifts in cell OCR for human renal epithelial cells cultured on a porous membrane between two microchannels and exposed to unidirectional perfusion for several days, mimicking the flow conditions in the kidney. Existing oxygen sensor-integrated OOC systems used for the measurement of drug-induced OCR shifts have been limited to one device per drug condition20,27,45. Our work demonstrates an improvement in throughput capability for drug investigations in OOC systems by measuring the OCR responses for three different drug treatments, in addition to a control group, with a minimum of three devices per condition in a single microtiter plate format. We found that the measurement of control devices before, during, and after drug exposure was particularly important for assessing whether changes in OCR were a result of drug action or common error sources, such as variability in cell number, cellular changes over time or due to disturbance, or other environmental changes, such as temperature or pH. It was only necessary to use 16% of the devices arrayed within the O-MCP for proof of concept work here. However, the remaining capacity of the O-MCP presents an immediate opportunity to include additional doses, drugs, biological conditions, or other parameters that would expand the scope of the experiment. Additionally, in future work, an increase in throughput could be realized by automating the sequential measurement procedure described in this work and allowing for a duration of 1.6–3.2 hours per plate (1–2 minutes/device). Alternatively, incorporating an array of optical fibers that collect data from each sensor unit simultaneously would increase the data collection speed and allow for measurement in all 96 devices within 1--2 minutes. In future work, achieving full automation and fast data collection will also enable many samples to be collected in a single device under the same conditions, which will allow thorough evaluation of the reproducibility of biological data collected in OOC studies. In a recent study, large sample sizes collected under controlled conditions enabled evaluation of data reproducibility for a cell migration assay50.
In conclusion, we presented an oxygen sensor-integrated OOC platform (O-MCP) and an approach to measure OCR in an array of membrane bilayer devices contained within a microtiter plate format. The integrated sensing platform and measurement approach enabled monitoring of cell metabolic activity for perfused tissues in an industry-standard format that is compatible with life science infrastructure such as high-content imaging. Data collection from the O-MCP did not significantly alter the OCR measurements, as demonstrated by the negligible effect of repeatedly modulating flow on and off on individual device readouts. Finite element analysis-based modeling resulted in the estimation of single-cell OCR data, allowing comparison with cell metabolic rates measured in other cell culture systems. Finally, we demonstrated the sensitivity of the OCR measurements for label-free detection of metabolic shifts in hRPTECs following exposure to three different drugs known to interfere with mitochondrial function. The O-MCP system is capable of collecting label-free metabolic data in an array of membrane bilayer devices contained within a microtiter plate format, which will serve as a powerful tool for studying drugs and disease in flow-based tissue models.
Materials and methods
O-MCP and micropump array
Optical oxygen-sensitive sensor units (0.75 mm in diameter and 50 micron thick) were cut with a biopsy punch from a 25 cm2 sheet of photosensitive oxygen sensor foil (item No. OXFOIL-TN, Pyroscience, Germany). Integration of sensor units and fabrication of the O-MCP assembly has been previously described in detail29. Briefly, 188 μm-thick cyclic olefin polymer (COP) (ZF14-188: Zeon Corp., Tokyo, Japan) with 96 laser-cut microchannels was laminated to 188 μm-thick COP in a heated hydraulic press (Carver Inc., Wabash, IN, USA) at 120 °C and 1 MPa for 30 minutes to form a bottom microchannel layer. Sensor units were positioned in the center floor of each bottom microchannel with forceps and bonded using silicone adhesive (Sylgard 184, Corning). Lamination of 188 μm-thick COP to a 188 μm-thick COP layer with 384 holes positioned at the inlet and outlets of each microchannel formed the top microchannel layer. An 11 μm-thick polycarbonate track-etched membrane with 1 μm pores (Sterlitech, WA, USA) was patterned using a UV laser system (Protolaser U4: LPKF Laser and Electronics, Garbsen, Germany) with 384 holes positioned at the inlets and outlets of each microchannel. The membrane was laminated between the bottom and top microchannel layers to form the microfluidic stack. The microfluidic stack was bonded with a pressure-sensitive adhesive to the bottom of a custom bottomless 384-well plate to form the O-MCP. The fabrication of a 192 micropump array that generated controlled flow rates in the top and bottom microchannels of each O-MCP device was done as previously described29. Briefly, the micropump array consisted of a pneumatic manifold layer, a membrane, and a fluidic circuit consisting of an intake valve, a pump chamber, and an expulsion valve. The micropump array sat on the O-MCP and interfaced with custom software to enable programmable flow rates ranging from 1–70 μL/min in each microchannel.
hRPTEC culture medium (R-medium) was prepared by supplementing 50:50 DMEM/F12 (Gibco, USA) with 0.5% fetal bovine serum (Life Technologies, USA), 10 ng/mL recombinant human epidermal growth factor (Thermo Fisher, USA), 5 µg/mL insulin (Sigma‒Aldrich, USA), 0.5 µg/mL hydrocortisone (Sigma‒Aldrich, USA), 0.5 µg/mL (±)-epinephrine (Cayman Chemical, USA), 6.5 ng/mL 3,3’,5-triiodo-L-thyronine sodium salt (Sigma‒Aldrich, USA), 10 µg/mL transferrin, human (Sigma‒Aldrich, USA), and 1% antibiotic-antimycotic (Life Technologies, Canada). Primary hRPTECs (ScienCell, Lot: 5340) and R-medium were cryopreserved at −190 °C in cryogenic vials at a density of 1 million cells/mL. Two days prior to seeding cells in the O-MCP microchannels, a 1 mL cryopreserved solution of hRPTECs was thawed and transferred to a T-150 flask (Thermo Fisher, USA) with 30 mL of R-medium. The flask was kept in an incubator at 37 °C, 50% humidity, and 5% CO2, and the medium was exchanged after 24 hours. On the day of seeding, hRPTECs reached approximately 90% confluency and were then rinsed with phosphate-buffered saline (PBS) (Thermo Fisher, USA), detached with 5 mL of 0.25% trypsin-EDTA (Life Technologies, USA), diluted in 10 mL of R-medium, and transferred to a 10 mL conical tube. hRPTECs were counted, and then the 10 mL cell solution was centrifuged at 250 g for 5 minutes to form the supernatant. The R-medium above the supernatant was aspirated, and the cells were resuspended in R-medium to form a one million cells/mL solution.
The O-MCP microchannels were sterilized with ethylene oxide gas and then degassed for 2 days. The microchannels were exposed to oxygen plasma treatment for 1 minute to increase the hydrophilicity of the microchannel surfaces. Microchannels were filled with ethanol, remained filled for 20 minutes, and then rinsed three times with PBS. Microchannels were then filled with a solution of 60 μg/mL collagen from human placenta (Sigma Aldrich, USA) in PBS, and the culture plate was rocked for 1 hour at room temperature. Following three PBS rinses, 15 μL of R-medium was delivered to all microchannel inlet and outlet wells. Medium was aspirated from the top inlet well prior to cell seeding. Thirty microliters of a one million/mL solution of hRPTEC in R-medium was pipetted into the inlet well of each top microchannel. One hour following seeding, R-medium was replaced with 60 μl of fresh medium in all four inlet and outlet wells of each microchannel. Micropump array-driven flow started in all microchannels at 10 μl/min. Two days after seeding, the flow rate increased to 70 μl/min for the remainder of the experiment. R-medium changes occurred every 2 days and 1 hour prior to all oxygen measurements.
A FireStingO2 optical oxygen meter (Pyroscience, Germany) with an optical fiber was used to measure oxygen in each O-MCP device. During oxygen measurements, the O-MCP was placed on the stage of a confocal microscope with a cell culture incubation chamber (LSM700, Zeiss), and the optical fiber was secured parfocally onto the objective turret using a custom fixture (Fig. S4). Because the distance between the optical fiber and sensor unit influences the oxygen measurements, it was critical that the distance remained consistent for different devices. Therefore, the microscope’s 10x objective and programmable stage was used to visually locate each sensor unit and position the optical fiber beneath each sensor unit at a consistent distance for different devices. The programmed stage positions were used to align the optical fiber with each sensor unit during measurements. A typical 2-point calibration was performed in FireStingO2 software using microchannels filled with water for the “100% saturated” solution and microchannels filled with 30 g/L sodium sulfite in deionized water for the “0% saturated” solution. Single-device oxygen depletion measurements were acquired at a continuous 1 Hz sampling rate as flow at 70 µL/min was turned on within the top and bottom microchannels for 10 seconds and then turned off for 1 minute.
The drugs antimycin A (Anti), oligomycin (Oligo), and carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) in powder form were purchased from Abcam (Cambridge, UK), and dimethyl sulfoxide (DMSO) was purchased from Sigma Aldrich (St. Louis, MO). All drugs were diluted in DMSO to produce 8 mM Anti, 3 mM Oligo, and 8 mM FCCP stock solutions. The drug-DMSO stock solutions were further diluted in R-medium to produce drug-R-medium solutions of 18 μM Anti, 18 μM Oligo, and 24 μM FCCP. Prior to the acquisition of oxygen data following drug treatments, the micropump array was lifted off of the O-MCP, and 10 μL of each drug-R-medium solution was pipetted into the inlet and outlet wells of the top and bottom microchannels to produce final solutions of 1.5 μM Anti (0.02% DMSO), 1.5 μM Oligo (0.05% DMSO), and 2 μM FCCP (0.025% DMSO) in R-medium within each microchannel. Following drug exposure, the flow rate was set to 70 μL/min in both microchannels for 23 minutes prior to OCR measurements.
Fluorescent staining and microscopic image acquisition
Live cells were stained using a 1 mg/ml stock solution of calcein AM (Abcam, USA) diluted to 1:1000 in PBS. For fluorescent staining, cells were rinsed with cold PBS three times. Cells were then fixed with 4% paraformaldehyde (Thermo Fisher) in PBS for 10 minutes followed by three rinses with PBS. Cells were permeabilized with 0.1% Triton-X (Thermo Fisher, USA) with PBS for 5–10 minutes at room temperature followed by three PBS rinses. Cell nuclei were labeled with a 1 mg/mL solution of Hoechst 33342 (Thermo Fisher, USA) diluted to 1:500 in PBS. Actin was labeled with phalloidin 647 (Thermo Fisher, USA) diluted to 1:1000 in PBS. Images were acquired with a scanning confocal microscope (LSM700, Zeiss) using ×10 air, ×20 air, and ×40 water immersion objectives and 405 nm, 488, and 637 nm lasers.
Images of nuclei for 4328 × 328 μm2 regions of interest were captured along the membrane of each top microchannel. Manual nuclei counts of the 328 × 328 μm2 images were performed using a Fiji plug-in titled Cell Counter51 and averaged for each microchannel. Each microchannel’s average nuclei count was divided by the surface area of the 328 × 328 μm2 region of interest to compute cell density. The total number of cells along the membrane in the microchannel overlap region was computed by multiplying the cell density by the surface area of the top surface of the membrane.
Single-factor analysis of variance and Tukey’s post hoc analysis were used to calculate significant differences between different groups. All n values represent the number of devices measured per condition. All error bars represent ± standard deviation.
Data that support the findings of this study are available from the corresponding authors upon reasonable request.
Scannell, J. W., Blanckley, A., Boldon, H. & Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Disco. 11, 191–200 (2012).
Borenstein, J. T., Tandon, V., Tao, S. L. & Charest, J. L. Microfluidic Cell Culture Systems. (Elsevier, 2018).
Vedula, E. M., Alonso, J. L., Arnaout, M. A. & Charest, J. L. A microfluidic renal proximal tubule with active reabsorptive function. PLOS ONE 12, e0184330 (2017).
Benam, K. H. et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat. Methods 13, 151–157 (2016).
Gard, A. L. et al. High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitro. Sci. Rep. 11, 14961 (2021).
Agarwal, A., Goss, J. A., Cho, A., McCain, M. L. & Parker, K. K. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip 13, 3599 (2013).
Rogers, M. T. et al. A high-throughput microfluidic bilayer co-culture platform to study endothelial-pericyte interactions. Sci. Rep. 11, 12225 (2021).
Kim, H. J. & Ingber, D. E. Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr. Biol. 5, 1130 (2013).
Frohlich, E. M., Zhang, X. & Charest, J. L. The use of controlled surface topography and flow-induced shear stress to influence renal epithelial cell function. Integr. Biol. 4, 75–83 (2012).
Yin, L. et al. Efficient drug screening and nephrotoxicity assessment on co-culture microfluidic kidney chip. Sci. Rep. 10, 6568 (2020).
Kratz, H. öll, Schuller, Ertl & Rothbauer Latest trends in biosensing for microphysiological organs-on-a-chip and body-on-a-chip systems. Biosensors 9, 110 (2019).
Shaughnessey, E.M., Kann, S.H., Azizgolshani, H. et al. Evaluation of rapid transepithelial electrical resistance (TEER) measurement as a metric of kidney toxicity in a high-throughput microfluidic culture system. Sci Rep 12, 13182 (2022). https://doi.org/10.1038/s41598-022-16590-9.
Ren, Q. et al. Shear stress and oxygen availability drive differential changes in opossum kidney proximal tubule cell metabolism and endocytosis. Traffic 20, 448–459 (2019).
Wilson, D. F. Oxidative phosphorylation: regulation and role in cellular and tissue metabolism: oxidative phosphorylation: role in cell and tissue metabolism. J. Physiol. 595, 7023–7038 (2017).
Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 13, 629–646 (2017).
Saxena, S., Mathur, A. & Kakkar, P. Critical role of mitochondrial dysfunction and impaired mitophagy in diabetic nephropathy. J. Cell Physiol. 234, 19223–19236 (2019).
Zhang, X., Agborbesong, E. & Li, X. The role of mitochondria in acute kidney injury and chronic kidney disease and its therapeutic potential. IJMS 22, 11253 (2021).
Tanumihardja, E. et al. Measuring both pH and O 2 with a single on-chip sensor in cultures of human pluripotent stem cell-derived cardiomyocytes to track induced changes in cellular metabolism. ACS Sens 6, 267–274 (2021).
Weltin, A. et al. Cell culture monitoring for drug screening and cancer research: a transparent, microfluidic, multi-sensor microsystem. Lab Chip 14, 138–146 (2014).
Moya, A. et al. Online oxygen monitoring using integrated inkjet-printed sensors in a liver-on-a-chip system. Lab Chip 18, 2023–2035 (2018).
Wolfbeis, O. S. Luminescent sensing and imaging of oxygen: fierce competition to the clark electrode. BioEssays 37, 921–928 (2015).
Grist, S. M., Chrostowski, L. & Cheung, K. C. Optical oxygen sensors for applications in microfluidic cell culture. Sensors 10, 9286–9316 (2010).
Ehgartner, J. et al. Online analysis of oxygen inside silicon-glass microreactors with integrated optical sensors. Sens. Actuators B: Chem. 228, 748–757 (2016).
Koopman, M. et al. A screening-based platform for the assessment of cellular respiration in Caenorhabditis elegans. Nat. Protoc. 11, 1798–1816 (2016).
Wolf, P. et al. Automated platform for sensor-based monitoring and controlled assays of living cells and tissues. Biosens. Bioelectron. 50, 111–117 (2013).
Krenger, R., Cornaglia, M., Lehnert, T. & Gijs, M. A. M. Microfluidic system for Caenorhabditis elegans culture and oxygen consumption rate measurements. Lab Chip 20, 126–135 (2020).
Zirath, H. et al. Bridging the academic–industrial gap: application of an oxygen and pH sensor-integrated lab-on-a-chip in nanotoxicology. Lab Chip (2021) https://doi.org/10.1039/D1LC00528F.
Bunge, F. et al. Microfluidic oxygen sensor system as a tool to monitor the metabolism of mammalian cells. Sens. Actuators B: Chem. 289, 24–31 (2019).
Azizgolshani, H. et al. High-throughput organ-on-chip platform with integrated programmable fluid flow and real-time sensing for complex tissue models in drug development workflows. Lab Chip 21, 1454–1474 (2021).
Trietsch, S. J., Israëls, G. D., Joore, J., Hankemeier, T. & Vulto, P. Microfluidic titer plate for stratified 3D cell culture. Lab Chip 13, 3548 (2013).
Jang, K.-J. et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr. Biol. 5, 1119–1129 (2013).
Nieskens, T. T. G., Persson, M., Kelly, E. J. & Sjögren, A.-K. A multicompartment human kidney proximal tubule-on-a-chip replicates cell polarization–dependent cisplatin toxicity. Drug Metab. Dispos. 48, 1303–1311 (2020).
van der Helm, M. W. et al. Non-invasive sensing of transepithelial barrier function and tissue differentiation in organs-on-chips using impedance spectroscopy. Lab Chip 19, 452–463 (2019).
Vormann, M. K. et al. Nephrotoxicity and kidney transport assessment on 3D perfused proximal tubules. AAPS J. 20, 90 (2018).
Verschuren, E. H. J. et al. Sensing of tubular flow and renal electrolyte transport. Nat. Rev. Nephrol. 16, 337–351 (2020).
Hedenqvist, M. S. Barrier packaging materials. in Handbook of Environmental Degradation of Materials 833–862 (Elsevier, 2012). https://doi.org/10.1016/B978-1-4377-3455-3.00027-4.
Inamdar, N. K., Griffith, L. G. & Borenstein, J. T. Transport and shear in a microfluidic membrane bilayer device for cell culture. Biomicrofluidics 5, 022213 (2011).
Luttropp, D., Schade, M., Baer, P. C. & Bereiter-Hahn, J. Respiration rate in human primary renal proximal and early distal tubular cells in vitro: Considerations for biohybrid renal devices. Biotechnol. Prog. 27, 262–268 (2011).
LeVeque, R. J. Finite difference methods for ordinary and partial differential equations: steady-state and time-dependent problems. (Society for Industrial and Applied Mathematics, 2007).
Vendruscolo, F., Rossi, M. J., Schmidell, W. & Ninow, J. L. Determination of oxygen solubility in liquid media. ISRN Chem. Eng. 2012, 1–5 (2012).
Smolina, N., Bruton, J., Kostareva, A. & Sejersen, T. Assaying mitochondrial respiration as an indicator of cellular metabolism and fitness. in Cell Viability Assays (eds. Gilbert, D. F. & Friedrich, O.) vol. 1601 79–87 (Springer New York, 2017).
Gerencser, A. A. et al. Quantitative microplate-based respirometry with correction for oxygen diffusion. Anal. Chem. 81, 6868–6878 (2009).
Pickard, J. M., Zeng, M. Y., Caruso, R. & Núñez, G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279, 70–89 (2017).
Park, T.-E. et al. Hypoxia-enhanced blood-brain barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat. Commun. 10, 2621 (2019).
Müller, B. et al. Measurement of respiration and acidification rates of mammalian cells in thermoplastic microfluidic devices. Sens. Actuators B: Chem. 334, 129664 (2021).
Lederle, M., Tric, M., Packi, C., Werner, T. & Wiedemann, P. An optical biosensor for continuous glucose monitoring in animal cell cultures. in Animal Cell Biotechnology (ed. Pörtner, R.) vol. 2095 319–333 (Springer USA, 2020).
Wagner, B. A., Venkataraman, S. & Buettner, G. R. The rate of oxygen utilization by cells. Free Radic. Biol. Med. 51, 700–712 (2011).
Beeson, C. C., Beeson, G. C. & Schnellmann, R. G. A high-throughput respirometric assay for mitochondrial biogenesis and toxicity. Anal. Biochem. 404, 75–81 (2010).
Quoilin, C., Mouithys-Mickalad, A., Duranteau, J., Gallez, B. & Hoebeke, M. Endotoxin-induced basal respiration alterations of renal HK-2 cells: a sign of pathologic metabolism down-regulation. Biochem. Biophys. Res. Commun. 423, 350–354 (2012).
Yin, D., Zhang, H., Yang, C., Zhang, W. & Yang, S. A more biomimetic cell migration assay with high reliability and its applications. Pharmaceuticals 15, 695 (2022).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
The authors would like to acknowledge significant contributors to this work. Brian Cain and Yazmin Obi for fabrication of the microfluidic culture plate and micropump array. Alex Markoski for providing guidance on the sensor fabrication and oxygen measurement procedure. Robert J de St. Phalle for graphic design and artwork. This material is based upon work supported by the National Science Foundation under Grant nos. 1804845 and 1804787. Any opinions, findings, and conclusions, or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.
Conflict of interest
The authors declare no competing interests.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kann, S.H., Shaughnessey, E.M., Coppeta, J.R. et al. Measurement of oxygen consumption rates of human renal proximal tubule cells in an array of organ-on-chip devices to monitor drug-induced metabolic shifts. Microsyst Nanoeng 8, 109 (2022). https://doi.org/10.1038/s41378-022-00442-7